Send the following on WhatsApp
Continue to Chathttps://nl.marketscreener.com/koers/aandeel/SCANDION-ONCOLOGY-A-S-118558682/nieuws/Scandion-Oncology-meldt-positieve-topline-Fase-IIa-gegevens-van-de-CORIST-Deel-3-studie-45850203/?utm_source=whatsapp&utm_medium=social&utm_campaign=share